Division of Vascular and Endovascular Surgery, Department of Surgery, Boston Medical Center, Chobanian and Avedisian School of Medicine, Boston University, 85 E. Concord St, Boston, MA 02118.
Division of Vascular and Endovascular Surgery, Department of Surgery, Boston Medical Center, Chobanian and Avedisian School of Medicine, Boston University, 85 E. Concord St, Boston, MA 02118.
Semin Vasc Surg. 2023 Sep;36(3):426-429. doi: 10.1053/j.semvascsurg.2023.06.002. Epub 2023 Jun 24.
The promise of artificial intelligence (AI) in health care has propelled a significant uptrend in the number of clinical trials in AI and global market spending in this novel technology. In vascular surgery, this technology has the ability to diagnose disease, predict disease outcomes, and assist with image-guided surgery. As we enter an era of rapid change, it is critical to evaluate the ethical concerns of AI, particularly as it may impact patient safety and privacy. This is particularly important to discuss in the early stages of AI, as technology frequently outpaces the policies and ethical guidelines regulating it. Issues at the forefront include patient privacy and confidentiality, protection of patient autonomy and informed consent, accuracy and applicability of this technology, and propagation of health care disparities. Vascular surgeons should be equipped to work with AI, as well as discuss its novel risks to patient safety and privacy.
人工智能（AI）在医疗保健领域的前景推动了 AI 临床试验数量和这项新技术全球市场支出的显著增长。在血管外科学领域，这项技术具有诊断疾病、预测疾病结果和辅助图像引导手术的能力。随着我们进入一个快速变化的时代，评估 AI 的伦理问题至关重要，特别是因为它可能会影响患者的安全和隐私。在 AI 的早期阶段，这一点尤为重要，因为技术的发展速度常常超过监管它的政策和伦理准则。当前面临的问题包括患者的隐私和保密性、保护患者自主权和知情同意、该技术的准确性和适用性，以及医疗保健差距的扩大。血管外科医生应该具备与 AI 合作的能力，并讨论其对患者安全和隐私的新风险。
